Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development.
about
DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down SyndromeMouse models of Down syndrome as a tool to unravel the causes of mental disabilitiesPCP4 (PEP19) overexpression induces premature neuronal differentiation associated with Ca(2+) /calmodulin-dependent kinase II-δ activation in mouse models of Down syndrome.Expression in aneuploid Drosophila S2 cells.Comparable low-level mosaicism in affected and non affected tissue of a complex CDH patientGene expression profiling in a mouse model identifies fetal liver- and placenta-derived potential biomarkers for Down Syndrome screening.Functional transcriptome analysis of the postnatal brain of the Ts1Cje mouse model for Down syndrome reveals global disruption of interferon-related molecular networksNoninvasive prenatal testing creates an opportunity for antenatal treatment of Down syndrome.Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling Down syndrome.Mouse models for Down syndrome-associated developmental cognitive disabilitiesThe use of mouse models for understanding the biology of down syndrome and agingIncreased excitability and altered action potential waveform in cerebellar granule neurons of the Ts65Dn mouse model of Down syndromeSensitized phenotypic screening identifies gene dosage sensitive region on chromosome 11 that predisposes to disease in miceMolecular and cellular alterations in Down syndrome: toward the identification of targets for therapeuticsDown syndrome and the molecular pathogenesis resulting from trisomy of human chromosome 21.Stem and progenitor cell dysfunction in human trisomies.Mouse-based genetic modeling and analysis of Down syndrome.Analysis of adult cerebral cortex and hippocampus transcriptomes reveals unique molecular changes in the Ts1Cje mouse model of down syndrome.A Comprehensive Diverse '-omics' Approach to Better Understanding the Molecular Pathomechanisms of Down Syndrome.Rodent models in Down syndrome research: impact and future opportunities.Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.Aneuploidy causes tissue-specific qualitative changes in global gene expression patterns in maize.Prenatal diagnosis of posterior fossa anomalies: Additional value of chromosomal microarray analysis in fetuses with cerebellar hypoplasia.Restrained Phosphatidylcholine Synthesis in a Cellular Model of Down's Syndrome is Associated with the Overexpression of Dyrk1A.Non-trisomic homeobox gene expression during craniofacial development in the Ts65Dn mouse model of Down syndrome.The fetal brain transcriptome and neonatal behavioral phenotype in the Ts1Cje mouse model of Down syndrome.Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome.
P2860
Q26745413-95A496FF-EF5F-4558-AE8A-9B839A6C5554Q26863005-477CC652-7DD0-4E90-A276-5D857F53D0C5Q30668603-3AB53B99-2A5C-44F5-B84B-12EE15871CAAQ33534633-C4F395E4-D803-47A7-802D-427059960572Q33784873-86138012-75E4-4248-A66C-50D9BC3ACAD7Q33886427-104D3FA4-9A2C-4A0A-BE7D-6664ECFBA1ABQ34012056-AA7C5091-D608-49B8-BF91-0084A2FBDDA7Q34339997-6C531043-E12C-401F-9F68-5346CA1CC0BDQ35573506-202CBB83-D491-402B-8BD9-07B2A5FC6DD7Q35661597-76F3D8DD-63AB-4212-B273-B25117F96125Q35810481-A176AA31-C147-4088-8B38-58FFAF752833Q36075008-427E8CB1-0187-4DA4-80E7-D563E8E6F670Q36108365-444A8BB9-54A4-48F4-9306-F096A508BFA0Q36111546-C23D7C41-CD20-4498-8FFF-27DCF47FCA21Q36681400-4DF79181-9F53-46F3-8F7F-DD6702EDB242Q38292512-B8A1E483-FAB2-48B1-BD73-497F45B9B8A0Q38993138-2335F74D-AF14-481A-ADEC-C625C3468E9CQ39177661-822698C4-3058-4970-9B44-D5B39CD78FD1Q39254480-79C50035-A8A9-4266-A2E4-85A6C1DA87CEQ46193918-C0B0F557-2801-4347-A598-9D99E1C03C8BQ46652242-72A0C49F-7734-4F3D-AF30-04FB2F0483A0Q46989412-962BC94A-FE34-4922-9050-0B9556D015BFQ48243324-9C0611F3-9E97-4E36-AD78-3382BF589057Q48952965-1981D7B5-18E0-4A33-A278-AED20B0845A4Q52642037-BC0191F8-FCF9-42B0-A252-86F8DE7D5A20Q54988096-C38BC308-916A-45C1-8CD5-6B8A6CFBAC3BQ55456404-54993E77-CC13-4865-9A22-E17C47FB5BD3
P2860
Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Gene expression signature of c ...... during postnatal development.
@ast
Gene expression signature of c ...... during postnatal development.
@en
type
label
Gene expression signature of c ...... during postnatal development.
@ast
Gene expression signature of c ...... during postnatal development.
@en
prefLabel
Gene expression signature of c ...... during postnatal development.
@ast
Gene expression signature of c ...... during postnatal development.
@en
P2093
P2860
P50
P356
P1433
P1476
Gene expression signature of c ...... during postnatal development.
@en
P2093
Benoit Larrat
Fabien Pasteau
Isabelle Rivals
Julien Laffaire
Luce Dauphinot
Ralph Sinkus
Randal X Moldrich
Rosine Wehrle
P2860
P2888
P356
10.1186/1471-2164-10-138
P407
P577
2009-03-30T00:00:00Z
P5875
P6179
1047139345